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Nucleotide binding by TAP mediates association with peptide
and release of assembled MHC class I molecules
Michael R. Knittler*, Philipp Alberts*, Edward V. Deverson†
and Jonathan C. Howard*
Background: Newly synthesised peptide-receptive major histocompatibility
complex (MHC) class I molecules form a transient loading complex in the
endoplasmic reticulum with the transporter associated with antigen processing
(TAP) and a set of accessory proteins. Binding of peptide to the MHC class I
molecule is necessary for dissociation of the MHC class I molecule from the
complex with TAP, but other components of the complex might also be
involved. To investigate the role of TAP in this process, mutations that block
nucleotide binding were introduced into the ATP-binding site of TAP.
Results: Mutant TAP formed apparently normal loading complexes with MHC
class I molecules and accessory components, but had no nucleotide-binding or
peptide-transport activity. Nevertheless, whereas wild-type loading complexes in
detergent lysates could be dissociated by addition of peptides that bind MHC
class I molecules, mutant complexes could not be dissociated in this way.
Depletion of nucleotide diphosphates or triphosphates from wild-type lysates
blocked peptide-mediated dissociation of MHC class I molecules, which could
be reversed by readdition of nucleotide diphosphates or triphosphates.
Complexes between mutant TAP and MHC class I molecules remained
associated in vivo until they were degraded. Disruption of nucleotide binding
also eliminated TAP’s peptide-binding activity.
Conclusions: Peptide-mediated dissociation of the MHC class I molecule from
the loading complex depends on conformational signals arising from TAP.
Integrity of the nucleotide-binding site is required not only for transmission of this
conformational signal to the loading complex, but also for binding of peptide to
TAP. Thus, the dynamic activity of the loading complex is synchronised with the
nucleotide-mediated peptide-binding and transport cycle of TAP.
Background
ATP-binding cassette (ABC) transporters use the energy of
ATP hydrolysis to drive a variety of substrates through cel-
lular membranes. All have, in common, a four-domain
structure comprising two transmembrane and two
nucleotide-binding domains (NBDs) with extensively con-
served sequence elements, and represent the largest gene
family. The transporter associated with antigen processing
(TAP) is a heterodimeric member of the superfamily. TAP
is localised in the membrane of the vertebrate endoplasmic
reticulum (ER) and is a critical part of the machinery of
antigen presentation associated with major histocompatibil-
ity complex (MHC) class I molecules. TAP transports short
peptides, generated in the cytosol by the proteasome, into
the ER lumen where they load into the peptide-binding
groove of MHC class I molecules. TAP forms a ‘loading
complex’ with newly-formed MHC class I molecules
through a bridging protein, tapasin, and two chaperones,
calreticulin and ERp57. The apparent stoichiometry of the
complex is 1 TAP:4 tapasin–MHC class I–calreticulin [1].
Binding of the MHC class I molecule to peptide causes the
MHC class I molecule to dissociate from the loading
complex [2,3]. This dissociation is peptide-specific with
respect to the MHC class I allele involved [2–4], suggesting
that a peptide-induced conformational change in the MHC
class I molecule [5] itself triggers undocking from the TAP
complex. Here, we investigated the proposal by Elliott [6]
that conformational changes in TAP — driven, as in other
members of the ABC transporter family, by binding and
hydrolysis of ATP during the transport cycle — might
promote the undocking of loaded MHC class I molecules.
To disrupt nucleotide binding by TAP, we introduced
mutations within TAP at a sequence motif known as the
Walker A site. We found that nucleotide binding by TAP
was indeed required for peptide-mediated dissociation of
the MHC class I molecule from the TAP complex. Our
findings also suggest that the uptake of peptide substrates
by TAP depends strictly on conformational properties
determined by the nucleotide-binding state. We propose a
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kinetic model in which nucleotide binding by TAP coor-
dinates the uptake and subsequent transport of peptides
with the binding, loading and release of MHC class I mol-
ecules from the loading complex.
Results
Mutant transporters form normal loading complexes but
lack nucleotide-binding and peptide-transport activity
Expression of wild-type rat TAP in the TAP-deficient
human cell line T2 restores normal assembly and surface
expression of MHC class I molecules [7]. In such cells, the
human MHC class I molecules, tapasin and calreticulin
form a loading complex with rat TAP [8]. We reconstituted
T2 cells with mutant rat TAP cDNAs in which the
nucleotide-binding sites of the two TAP chains, TAP1 and
TAP2, had both been disrupted. In the TAP mutants that
we designate MUT I, we replaced the glycine residues in
the Walker A motif — at positions 515 and 520 in the case
of TAP1, and 503 and 508 in the case of TAP2 — with
valine. In the MUT II mutants, the same glycine residues
were replaced in both TAP chains with serine. Both
glycines have a very high level of conservation in the
Walker A motif [9] and contribute to the binding site for
β-phosphate and γ-phosphate of nucleotides [10]. Further-
more, replacement of the glycines by serine or valine is
known to destroy function in other ABC transporters
[11,12]. The characteristics of the parental T2 cell line and
T2 transfectants expressing wild-type or mutant TAP
(MUT I and MUT II) are shown in Figures 1 and 2. 
Western blots of cell lysates confirmed expression of both
TAP chains in the transfectants (Figure 1a). T2 cells trans-
fected with MUT II appeared consistently to express
somewhat lower levels of TAP than T2 cells transfected
with wild-type TAP or the MUT I mutant. Nevertheless,
both mutant TAPs were physically assembled and could
form loading complexes comprising MHC class I mol-
ecules, tapasin, ERp57 and calreticulin that were indistin-
guishable from those formed by wild-type TAP
(Figure 1b). Thus, the mutations in the NBDs of TAP had
no apparent effect on the formation of the loading complex. 
To compare the nucleotide-binding activity of wild-type
and mutant TAP chains, aliquots of detergent-solubilised
cell membranes of the T2 transfectants were incubated
with different nucleotide–agarose resins (ATP, ADP and
AMP). Retained proteins were eluted with SDS-containing
buffer and analysed by western blot probed for TAP1 and
TAP2 (Figure 2a). Wild-type TAP was bound to agarose-
immobilised ATP and ADP but not to AMP. The speci-
ficity of TAP binding was confirmed by competition
experiments with free ATP (data not shown). No ATP-
binding activity was demonstrable for the two mutant
transporters and only a marginal binding to ADP–agarose
could be observed for MUT I (TAP2) and MUT II (TAP1
or TAP2). In the case of T2 cells transfected with MUT I,
some ADP binding was detectable for TAP1after a twofold
longer exposure (data not shown). Because of the weak
signal strength, variation in ADP binding is most likely due
to experimental limitations of the western blot technique.
Peptide transport from cytosol to ER by the mutant
TAPs compared with the wild type was analysed in per-
meabilised cells with a standard peptide-transport
assay [13] using the radioiodinated model peptide S8
(TVDNKTRYR, in the single-letter amino-acid
code) [14]. No peptide transport was found in the two
mutant cell lines above the background detected in
untransfected T2 cells (Figure 2b).
As expected from the lack of peptide transport, the mutant
TAPs were unable to support maturation of MHC class I
molecules in the transfectants. In pulse-chase experi-
ments, human leukocyte antigen HLA-B5 molecules in
T2 cells transfected with wild-type TAP acquired resis-
tance to endonuclease H, signalling exit from the ER, with
a half-life of about 90 minutes (Figure 3a). In contrast, in
T2 cells expressing MUT I or MUT II, HLA-B5 mol-
ecules remained sensitive to endonuclease H during the
whole chase period. The initial intensity of the signal 
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Figure 1
Expression and formation of complex by wild-type and mutant TAP.
(a) Expression of TAP subunits by transfected T2 cells as detected in
Triton X-100 lysates of 105 cells by western blotting with anti-rat TAP1
or anti-rat TAP2 antiserum. (b) Polypeptides coprecipitating with TAP2.
Immunoblots showing the presence of TAP2, TAP1, calreticulin, ERp57,
tapasin and MHC class I molecules in the loading complex in digitonin-
lysed T2 transfectants after immunoprecipitation (IP) with anti-rat TAP2
antiserum. Western blots were probed with antisera to TAP2, TAP1,
calreticulin, ERp57, tapasin and MHC class I molecules as indicated. 
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corresponding to the MHC class I molecules decreased
40–45% after 270 minutes, as revealed by phosphorimager
analysis. This suggests a difference between the apparent
half-lives of ER-localised HLA-B5 in T2 transfectants
expressing either wild-type or mutant TAP chains. Trans-
fection of the mutant TAPs also failed to increase the
surface expression of HLA-B5 MHC class I molecules
(detected using monoclonal antibody 4E) above the level
characteristic of untransfected T2 cells (Figure 3b).
Disruption of the nucleotide-binding site of TAP blocks
peptide-mediated release of MHC class I molecules
Dissociation of MHC class I molecules from TAP can be
triggered in vitro by incubation with suitable peptides that
bind MHC class I molecules [2–4]. We incubated digi-
tonin-solubilised T2 transfectants at 37°C with a 1:1
mixture of the peptides LLDVPTAAV and QPRAPIRPI,
which bind HLA-A2 and HLA-B5, respectively [15,16], in
increasing concentrations. Complexes associated with
TAP were then isolated with anti-TAP2 antiserum and
analysed by western blotting (Figure 4a). HLA class I mol-
ecules were released from wild-type TAP in a peptide-
dependent fashion. At 100 µM peptide, nearly no MHC
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Figure 2
(a) Nucleotide-binding properties of wild-type and mutant TAP.
Membrane fractions of T2 transfectants were resuspended in lysis
buffer and incubated with different nucleotides bound to agarose. For
MUT II, a twofold higher concentration of membranes was used. After
washing, proteins were eluted with SDS-containing sample buffer and
analysed in western blots probed for rat TAP1 and TAP2. (b) TAP-
mediated peptide transport. Transfected and untransfected T2 cells
were permeabilised with streptolysin O and incubated with 10 mM
ATP and radioiodinated peptide S8 (1.3 × 106 cpm). The graph shows
the amount of transported labelled peptides recovered.
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Figure 3
Maturation and surface expression of MHC class I molecules in
T2 transfectants. (a) Kinetics of maturation of MHC class I molecules.
Cells were metabolically labelled with [35S]methionine/cysteine for
30 min and chased as indicated. Triton X-100 lysates were precleared
in the presence of 100 µM HLA-B5-binding peptide to stabilise
unloaded HLA-B5. MHC class I molecules were immunoisolated with
monoclonal antibody 4E, which recognises HLA-B5, incubated with
endonuclease H and analysed by SDS–PAGE. The asterisks indicate
unidentified proteins. (b) Surface expression of MHC class I
molecules. Cells were incubated with monoclonal antibody 4E. After
incubation with a fluorescein isothiocyanate (FITC)-labelled secondary
antibody, surface expression of HLA-B5 was detected by flow
cytometry (shaded). Background staining was determined by
incubating only with secondary antibody (unshaded).
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class I molecules were found in the TAP complex. Consis-
tent with this result, we found, in stabilisation experiments
in vitro, that the effective loading concentration of MHC
class I molecules for these two peptides was 10–100 µM
(see supplementary material published with this article on
the internet). In contrast, no peptide-mediated release of
MHC class I molecules was found for the two mutant TAP
complexes. Thus, peptide-mediated release of MHC class
I molecules is critically sensitive to mutations that abro-
gate the nucleotide-binding capacity of TAP. 
We confirmed this phenomenon biochemically. Peptide-
dependent dissociation of the loading complex was
studied in detergent lysates of T2 cells expressing wild-
type TAP.  Cellular nucleotide diphosphates and triphos-
phates were depleted from the lysates by apyrase (see
supplementary material). Apyrase-treated and control
lysates were incubated with or without peptides that bind
MHC class I molecules. As shown in Figure 4b, no
peptide-induced dissociation of MHC class I molecules
was found in the nucleotide-depleted lysates of T2 cells
expressing wild-type TAP. Incubation with apyrase alone
had no detectable effect on the association between TAP
and MHC class I molecules in lysates. Thus, depletion of
nucleotide diphosphates and triphosphates from lysates
has the same blocking effect on peptide-mediated dissoci-
ation of MHC class I molecules from TAP as mutations in
the nucleotide-binding domain of TAP.
Peptide-mediated dissociation of MHC class I molecules
from TAP does not depend on nucleotide hydrolysis
We also investigated the peptide-mediated dissociation in
the rat cell line D7 [14] in which formation of the complex
between the non-permissive transporter TAP-B and MHC
class I RT1.Aa molecules has been studied previously [17].
In these cells, the TAP-B transporter cannot bind
(A. Seelig and J.C.H., unpublished data) or transport pep-
tides with the carboxy-terminal arginine required for suc-
cessful loading of RT1.Aa [18,19]. Thus, peptides can be
used that load efficiently onto MHC class I molecules but
do not serve as binding or transport substrates for TAP-B.
In experiments with D7 cells (Figure 5a), the nonameric
RT1.Aa-binding peptide B6, with two strong anchor
residues at position 2 and 9 [20], dissociated digitonin-sol-
ubilised loading complexes in a clear concentration-
dependent manner. A second RT1.Aa-binding peptide,
S2, was equally effective, whereas two non-binding pep-
tides, A8 and S5, were unable to induce dissociation of the
complex. Thus, in digitonin lysates of rat D7 cells, only
appropriate peptides that bind MHC class I molecules
induce release of RT1.Aa from the TAP complex.
As with the T2 transfectants, peptide-dependent dissocia-
tion of the complex was inhibited if the lysate was
depleted of nucleotide diphosphates and triphosphates
using apyrase (Figure 5b, lanes 1–3). Specific nucleotides
could restore peptide-dependent dissociation of the
loading complex in nucleotide-depleted lysates. B6
peptide-mediated dissociation of MHC class I molecules
was completely restored by addition of ATP at a physio-
logical concentration of 1 mM (lane 4).
Like other ABC transporters [21] TAP has a relatively
broad nucleotide specificity. All four nucleotide triphos-
phates are able to power peptide translocation by TAP
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Figure 4
Mutations in the NBD of TAP affect the
peptide-mediated release of MHC class I
molecules from TAP. (a) Peptide-mediated
dissociation of the complex. Digitonin-
solubilised T2 transfectants were incubated
for 60 min at 37°C with increasing
concentrations of a 1:1 mixture of two
peptides, one binds HLA-A2, and the other
HLA-B5. TAP-associated complexes were
immunoprecipitated with anti-rat TAP2
antiserum and analysed by western blotting.
The upper panel was immunostained with
anti-rat TAP2 antiserum, and the lower panel
with the antibody 3B10.7 which recognises
HLA-A and HLA-B. For MUT II, a twofold
higher concentrated lysate was used for
immunoisolation. (b) Peptide-mediated
dissociation is blocked by depletion of
nucleotides. Digitonin-solubilised T2 cells
expressing wild-type TAP were pre-incubated
with or without 0.5 U apyrase for 30 min at
room temperature. These lysates were then
supplemented with or without a 100 µM 1:1
mixture of the HLA-A2-binding peptide and
the HLA-B5-binding peptide. After a 60 min
incubation at 37°C, TAP-associated
complexes were immunoprecipitated
and analysed by western blotting as
described in (a).
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[22,23], and UTP, GTP, CTP and the nucleotide diphos-
phate ADP are binding competitors for ATP [24]. Figure 5b
shows that peptide-mediated dissociation was completely
restored to nucleotide-depleted lysates by ADP (lane 6) and
by the non-hydrolysable ATP analogue, ATPγS (lane 5) but
not by AMP (lane 7). UTP, CTP and GTP were also able to
restore peptide-mediated release of MHC class I molecules
from TAP (lanes 8–10). The broad spectrum of nucleotides
which restore peptide-mediated complex dissociation pro-
vides further evidence that peptide-dependent release of
MHC class I molecules is promoted by nucleotide binding
of TAP. Clearly, however, the contribution of TAP to
peptide-dependent release of MHC class I molecules is dis-
tinct from peptide transport as the latter is absolutely
dependent on nucleotide hydrolysis [22]. 
Mutant TAP is characterised by a fast turnover and
persistent interaction with MHC class I molecules
A reduced supply of loadable peptides results in the accu-
mulation of TAP-associated MHC class I molecules in the
ER [17,25]. Loading complexes assembled on TAP carry-
ing nucleotide-binding-site mutations showed no accumu-
lation of MHC class I molecules in the ER, however
(Figures 1,4). We therefore used pulse-chase analysis to
compare the duration of the interaction between MHC
class I molecules and either wild-type or mutant trans-
porters (Figure 6a). In T2 cells transfected with wild-type
TAP, the TAP signal remained nearly constant over the
whole chase period, implying almost no degradation over
this interval; the signal corresponding to the TAP-associ-
ated MHC class I molecules decreased with a half-life of
100 minutes (Figure 6b), corresponding roughly to the
maturation rate of MHC class I molecules (Figure 3a). In
contrast, the mutant TAPs appeared to have an increased
degradation rate, relative to the wild-type, and the appar-
ent half-life of the TAP-associated MHC class I molecules
was significantly extended. The signal intensities of
mutant TAPs and associated MHC class I molecules
decreased after 270 minutes to 40–45% of the initial value
(Figure 6b). In the complex between wild-type TAP and
MHC class I molecules, the signal intensity corresponding
to MHC class I molecules relative to TAP was reduced by
≥ 90% after a 270 minute chase, as pulse-labelled MHC
class I molecules load and leave the complex (Figure 6b).
In complexes between mutant TAP and MHC class I mol-
ecules, however, no change in the ratio of the signal inten-
sities occurred over the whole chase period (Figure 6b),
implying that the two components remained associated
until both entered the degradation pathway.
The loading of MHC class I molecules by peptides was
not, however, directly affected in the mutant loading com-
plexes. Immunoisolated loading complexes from metabol-
ically labelled T2 transfectants were loaded in 1%
digitonin buffer with the A2/B5 peptide mixture and the
complexes subsequently dissociated in Triton X-100.
Peptide-containing molecules were then re-precipitated
from the detergent mixture by the conformation-sensitive
antibody, W6/32, and visualised by autoradiography fol-
lowing SDS–PAGE. Figure 6c shows that peptide-loaded
MHC class I molecules could be recovered from both
wild-type and mutant loading complexes: the low specific
activity of labelled MHC class I molecules from the
MUTI or MUT II complexes compared with wild-type
TAP presumably results from the low turnover rate of
MHC class I molecules in these complexes (Figure 6a).
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Figure 5
Various nucleotides restore peptide-mediated release of MHC class I
molecules. (a) Peptides that bind MHC class I molecules induce
dissociation of TAP complexes in D7 cell lysates. Digitonin-solubilised
D7 cells were supplemented with increasing concentrations
(0–100 µM) of four different 9-mer peptides. RT1.Aa-specific anchor
residues are indicated in the sequences by bold letters. After incubation
with peptide for 30 min at room temperature, TAP complexes were
immunoisolated with anti-rat TAP2 antiserum and analysed by western
blotting. The upper part of the blot was stained with anti-rat TAP2
antiserum, the lower part with the antiserum F87, which is specific for
rat MHC class I RT1.A molecules. (b) Re-addition of nucleotides restore
complex dissociation. Digitonin lysates of D7 cells were pre-incubated
with or without apyrase as described in the Figure 4 legend. After
depletion of nucleotides and a subsequent inactivation of apyrase by
azide, the B6 peptide (10 µM) alone or in combination with 1 mM
nucleotides was added to the lysates. All samples were incubated for a
further 30 min at room temperature. Immunoprecipitation and western
blotting was performed as described in (a).
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The integrity of the nucleotide-binding site is required for
the binding of peptide to TAP
There are hints that there might be an interaction
between the peptide-binding and nucleotide-binding sites
of TAP [26]. We analysed this directly in streptolysin-O-
permeabilised T2 transfectants using a photoreactive
radioiodinated peptide substrate for TAP. TAP, with
covalently-bound labelled peptide, was immunoprecipi-
tated and analysed by SDS–PAGE. Figure 7 shows that
efficient peptide-crosslinking was detected only for wild-
type TAP. For both mutant transporters, no crosslinking
of peptide with TAP was detected above background. In
conclusion, both mutant transporters show a complete
elimination of peptide-binding activity. Thus, uptake of
peptide substrates by TAP depends on conformational
properties determined by nucleotide binding.
Discussion
The dissociation of the MHC class I molecule from the
TAP loading complex is initiated when a peptide of the
appropriate structure binds to the MHC class I molecule
[2,3], and it has been proposed that the peptide-induced
conformational change in the MHC class I molecule [5]
itself triggers dissociation [6]. This role of peptide is con-
firmed in the present study. We show, however, that
peptide-mediated release of the MHC class I molecule
from the TAP complex also depends on conformational
properties determined by the nucleotide-binding state of
TAP. When the nucleotide-binding sites of both TAP
subunits were disrupted (Figure 2), TAP did not release
MHC class I molecules in the presence of peptides that
bind MHC class I molecules (Figure 4a), although the
loading complex (Figure 1) and the loading of peptide
into MHC class I molecules (Figure 6c) appeared normal.
A phenocopy of the TAP mutation was achieved by
depletion of nucleotide diphosphates and triphosphates
from cellular extracts with apyrase (Figure 4b); this could
be reversed by re-addition of various nucleotide diphos-
phates and triphosphates (Figure 5) that have been shown
1004 Current Biology Vol 9 No 18
Figure 6
Characterisation of the interaction between TAP and MHC class I
molecules. (a) Kinetics of the interaction between TAP and MHC class I
molecules. Pulse–chase analysis was performed as described in the
Figure 3 legend. Cells were lysed in PBS containing 1% digitonin.
Immunoisolation of TAP-associated complexes was performed using
anti-rat TAP2 antiserum. For a better identification of TAP-associated
MHC class I molecules, immunoprecipitates were treated with
endonuclease H before SDS–PAGE. Asterisks indicate unidentified
proteins. (b) Following SDS–PAGE, the gel was exposed to
phosphorimager screens. The graph shows the relative signal intensities
of TAP and MHC class I molecules. (c) Peptide loading of TAP-bound
MHC class I molecules. T2 transfectants were metabolically labelled for
30 min. TAP complexes from digitonin lysates were immunoisolated
(PPT) with anti-rat TAP2 antiserum and incubated overnight with
100 µM of a 1:1 mixture of the HLA-A2-binding and HLA-B5-binding
peptides at 4°C. MHC class I molecules were released from TAP by
incubating the precipitates with 1% Triton X-100 at 37°C. Released
MHC class I molecules were reprecipitated (rPPT) with monoclonal
antibody W6/32, which recognises β2-microglobulin-asssociated
HLA-A, HLA-B and HLA-C, and analysed by SDS–PAGE.
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Figure 7
Mutations in the NBD of TAP affect binding of peptide substrates.
Cells permeabilised using streptolysin O were resuspended in binding
buffer and incubated with 1 µM radioiodinated and N-hydroxy-
succinimidyl-4-azidobenzoate (HSAB)-conjugated peptide S8. After
crosslinking, the cells were lysed and TAP was immunoprecipitated
from post-nuclear supernatants with anti-rat TAP2 antiserum (upper
panel). As a control, the amount of TAP in the corresponding lysates
was determined by western blotting using an anti-rat TAP2 antiserum
(lower panel).
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to bind to TAP [24]. As ADP and non-hydrolysable
ATPγS also restored peptide-mediated release of MHC
class I molecules, nucleotide hydrolysis is not needed for
disassembly of the complex (Figure 5b).
Although ATP hydrolysis is clearly required for substrate
transport by TAP [13,22] and other ABC transporters [21],
substantial nucleotide-induced conformational changes in
the molecule seem to be associated with the transport cycle
[27]. The prevailing model asserts that nucleotide-depen-
dent conformational changes in the NBD are transduced
into conformational changes in the membrane-spanning
domains [27]. For P-glycoprotein, binding of MgADP and
MgATP, but also non-hydrolysable ATP analogues such as
MgATPγS, significantly affect protein conformation in the
absence of substrate [28,29].
Mutations in the nucleotide-binding site not only affected
the release of assembled MHC class I molecules but also
eliminated the peptide-binding activity of TAP (Figure 7).
Thus, substrate uptake by TAP depends on conforma-
tional properties determined by the nucleotide-binding
state, and is therefore probably coupled to the transloca-
tion process. Communication between the NBD and sub-
strate-binding site has been reported for ABC transporters
involved in drug resistance [30,31], and cross-linking of
P-glycoprotein with a substrate predominantly labelled
fragments overlapping with transmembrane regions adja-
cent to the ATP-binding sites [32]. Interestingly, a
lowered affinity of P-glycoprotein for substrate is detected
when substrate binding is tested in the presence of vana-
date, which stabilises a transition state of the P-glyco-
protein transport cycle [33]. Thus, the nucleotide-empty
state of TAP might resemble what is normally a transient
conformation during the transport cycle in which peptide
is released into the lumen of the ER. Indeed, current
models of transport cycles for P-glycoprotein and cystic
fibrosis transmembrane conductance regulator (CFTR)
propose nucleotide free states occurring transiently during
exchange of nucleotides in the NBDs [34]. 
TAP molecules have been shown to bind radiolabelled
peptides in vitro at 4°C in the absence of added ATP [35].
Peptide binding is strongly temperature-dependent, with
very low or undetectable binding at temperatures over 4°C
[35] but can be stabilised at 37°C by addition of nucleotides
including ADP and ATPγS [26]. These results are fully
consistent with our own analysis and together suggest con-
formational cross-talk between the nucleotide-binding site
and the peptide-binding site. Further experiments of our
own show that peptide binding also reciprocally modifies
the nucleotide-binding site (P.A., J.C.H. and M.R.K.,
unpublished data). The location of the peptide-binding site
on the TAP protein is still unknown although first steps
have been taken towards its characterisation [14,36]. It
remains to be determined whether the NBDs of the two
TAP chains are functionally equivalent and are both
involved in the regulation of peptide uptake. Transfectants
expressing a mutant TAP1 with a wild-type TAP2 and vice
versa indicate functional differences between TAP1 and
TAP2 (P.A., J.C.H. and M.R.K., unpublished data).
In the present experiments, MHC class I molecules associ-
ated with TAP carrying mutations in the ATP-binding site
remained associated until they were degraded (Figure 6). In
addition, the biological half-life of the mutant transporters
seems to be reduced. In a previous study, accumulation in
the ER in rat cells of complexes between wild-type rat TAP
and MHC class I molecules was achieved by lack of deliv-
ery of loadable peptides as a result of the presence of an
inappropriate combination of TAP2 and MHC class I
alleles [17]. In this latter system, however, the biological
half-life of TAP was unaffected by the formation of stable
complexes with MHC class I molecules (K. Gülow and
M.R.K, unpublished observation). Thus, the accelerated
turnover of the mutant TAP in T2 cells cannot be
explained simply in terms of persisting interaction with
MHC class I molecules. Mutations in the nucleotide-
binding site may also cause structural instability which
shortens TAP half-life. This outcome may be general for
ABC transporters as mutations in the NBDs of CFTR are
also characterised by increased in vivo instability [37].
Our results provide hints towards a kinetic model of TAP
function in which the binding and then the transport of
peptide by TAP are kinetically coordinated with the
binding of peptide to the MHC class I molecule and the
subsequent release of the MHC class I molecule from the
loading complex. Our findings show that the nucleotide-
binding site is conformationally coupled both to the
peptide-binding site and to the MHC class I molecule.
TAP is probably linked to the MHC class I molecule only
through the recently-described ER membrane molecule,
tapasin [1], implying that the nucleotide-mediated confor-
mational contribution of TAP to the release of the MHC
class I molecule from the complex must be transduced
through tapasin. Nevertheless, tapasin deprived of its
transmembrane domain, which does not interact with TAP
but does interact with MHC class I molecules, appears to
function as efficiently in mediating peptide loading and
allowing release and maturation of MHC class I molecules
as TAP-associated tapasin [38]. Presumably such com-
plexes between MHC class I molecule and soluble tapasin
can be dissociated by peptide binding to MHC class I mol-
ecules alone in the absence of nucleotide. Association of
TAP with tapasin must therefore impose some structural
constraint on tapasin in order to enforce nucleotide-depen-
dence of MHC class I molecule release.
Why is loading of MHC class I molecules organised in asso-
ciation with TAP, and why are loading and release of MHC
class I molecules apparently coordinated so intimately with
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the transport cycle of TAP? The two possible explanations
that have been discussed in this context are, first, the zero-
length diffusion path for translocated 
peptides and their isomolar relationship to the loading
complex and, second, an opportunity for an editing reac-
tion whereby unstably bound peptides can be exchanged
for better ones. Although the first explanation makes
sense, soluble tapasin, which fully replaces the tapasin
defect in mutant cells but does not interact with TAP,
loads a set of peptides into MHC class I molecules that are
not distinguishably different at the level of analysis (bulk
high-performance liquid chromatography) from that
loaded in the presence of wild-type tapasin. Our idea that
the non-permissive TAP–MHC class I molecule complex
is formed when peptide is released by TAP would be con-
sistent with a process of peptide editing in the TAP
loading complex. The editing hypothesis, while still impre-
cise, has some attractions. Firstly, the stoichiometry of the
loading complex appears to be 1 TAP:4 tapasin–MHC
class I molecules [1]. Such a relationship, while structurally
complex, is easy to relate to the accidental structural rela-
tionship between the transported peptide and the avail-
able peptide-binding grooves of MHC class I molecules.
If each peptide had an opportunity under structurally
favourable conditions to inspect four peptide-binding
grooves for compatibility rather than just one, this would
appear to present advantages. Furthermore, the persistent
association of at least two chaperones (calreticulin and the
disulphide isomerase ERp57) with the loading complex
[39–41] suggests the potential for complex conformational
behaviour which could be associated with peptide
exchange on MHC class I molecules in the ER [42]. On
this view, it is likely that the mechanical and kinetic cou-
pling of loading and release of MHC class I molecules
with the TAP transport cycle may have something impor-
tant to do with events that occur in the loading complex
after peptide has been transported to the luminal side of
the ER membrane.
Conclusions
We report here that the physical interaction of the MHC
class I molecule with the loading complex is regulated
by nucleotide binding by TAP. Only after binding of
nucleotide by TAP does the complex become permis-
sive for peptide-induced release of the MHC class I mol-
ecule. Moreover, the integrity of the TAP
nucleotide-binding site is also required for peptide
binding by TAP. These results suggest that the binding
and release of MHC class I molecules by the loading
complex is directly coupled to the peptide-binding and
transport cycle of TAP. Although much has been learned
of the TAP transport system, little is known about the
central processes involved in substrate translocation by
any ABC transporter. Insights into the molecular mecha-
nism by which nucleotides induce conformational
changes in TAP may have to wait for a full-scale struc-
ture–function analysis and extensive inferences from
related transporters.
Materials and methods
Cell lines and cell culture
T2 is a human lymphoblastoid cell line which lacks both TAP genes,
and expresses only the HLA-A2 and HLA-B5 MHC class I molecules
[43]. T2 transfectants containing rat TAP1a and rat TAP2a, which have
been described previously [7], were cultured in IMDM (Gibco BRL)
supplemented with 1 mg/ml G418 (PAA, Cölbe). D7 cells, created by
double transfection of the rat T-cell lymphoma line C58 with cDNAs
encoding RT1.Aa and TAP2u [14], were maintained in culture as
described previously [17].
Cloning and expression of mutant TAP
Mutagenesis of the Walker A site in rat TAP2a and TAP1a cDNA [44,45]
was performed using the pALTER-1 in vitro mutagenesis system
(Promega) according to the manufacturer’s instructions. Mutagenic
oligonucleotides were: MUT I, 5′-GGTGCTCTTCACTGACC-
CATTGGGCACCACCAAAGC-3′; and MUT II, 5′-GGTGCTCTTGCT-
TGACCCATTGGGGCTCACCAAAGC-3′. The mutated constructs
were subcloned in pHβAPr-1-neo [46] and cotransfected with pPUR
(Invitrogen) into T2 cells by electroporation using a Bio-Rad gene
pulser at 270 V/550 µF. After selection with puromycin, transfectants
were subcloned and screened for expression of rat TAP by western
blotting. Stable transfectants were maintained in IMDM supplemented
with 750 ng/ml puromycin.
Immunoprecipitation and western blotting
Cells were solubilised in lysis buffer (50 mM Tris/HCl, pH 7.4, 150 mM
NaCl) containing 1% digitonin (Fluka) or 1% Triton X-100 (Sigma).
Lysis buffers were occasionally supplemented with 3 mM MgCl2, 5 mM
iodoacetamide (Sigma) and 0.5 mM PMSF (Boehringer Mannheim).
Immunoprecipitations with anti-rat TAP2 antiserum were performed as
described previously [17]. For characterisation of the complex, affinity-
purified anti-rat TAP2 antiserum was covalently coupled to oxirane
acrylic beads (Sigma) [47]. Competitive elution of TAP complexes and
western blotting was performed as described previously [17].
Pulse-chase analysis
Pulse-chase experiments were performed as described previously [17].
Flow cytometry
Cells were washed twice with DFN (PBS, 10% FCS, 0.01% NaN3,
9 mM CaCl2⋅2H2O, 5 mM MgCl2⋅6H2O) and incubated with mono-
clonal antibody 4E (anti-HLA-B antibody) for 30 min on ice, washed
three times in DFN and incubated with FITC-conjugated anti-mouse
IgG (Dianova) for a further 30 min. Analysis was performed on a FACS-
Scan flow cytometer (Becton Dickinson).
Transport assay
Cells (2 × 106) were permeabilised with streptolysin O (2 U/ml; Murex).
After washing with PBS, 0.5 µM radioiodinated peptide S8 (TVDNK-
TRYR), 10 mM ATP and incubation buffer containing 50 mM Hepes pH 7.5,
250 mM sucrose, 150 mM CH3COOK, 5 mM (CH3COO)2Mg.4H2O,
1 mM DTT, 1 mM leupeptin (Boehringer Mannheim), 1 mM Pefabloc
(Boehringer Mannheim) and 1.8 µg/ml aprotinin (Sigma) were added
and incubated for 10 min at 37°C. Following lysis with 20 mM Tris-HCl
pH 7.5, 500 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 0.1% Triton X-100
(Sigma), 0.1% Nonidet P-40 (Sigma), transported glycosylated pep-
tides were isolated with Con A–sepharose (Pharmacia) and quanti-
tated by gamma counting.
Nucleotide-binding assay
Cells were washed in TBS containing 3 mM MgCl2 and disrupted by
freezing and thawing. The suspension was spun at 1000 × g for
10 min at 4°C. The supernatant was centrifuged for 1 h at
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100,000 × g. Membrane pellets from 107 cells were resuspended in
500 µl lysis buffer, composed of TBS/MgCl2 containing 2% CHAPS
(Sigma), and incubated for 30 min on ice, followed by centrifugation at
10,000 × g for 30 min. Aliquots corresponding to 1.5 × 106 cells were
incubated with 50 µl nucleotide–agarose (Sigma) for 1 h at 4°C in
500 µl lysis buffer. After washing with lysis buffer, proteins were eluted
with SDS-containing sample buffer and analysed by western blots
probed for TAP1 and TAP2.
Peptide crosslinking assay
Cells (2 × 106) were permeabilised with streptolysin O (2 U/ml;
Murex). After washing with cold PBS, cells were resuspended in
100 µl binding buffer, which contained 50 mM Tris-HCl, pH 7.5,
5 mM (CH3COO)2Mg⋅4H2O, 1 mM CaCl2, 1 mM DTT, 1 mM leu-
peptin (Boehringer Mannheim), 1 mM Pefabloc (Boehringer
Mannheim), 1.8 µg/ml aprotinin (Sigma) and 0.1% dialysed dena-
tured BSA. Cells were incubated with 1 µM radioiodinated and
HSAB-conjugated peptide S8 (TVDNKTRYR). Crosslinking was
induced by irradiation with a UV lamp at 254 nm for 5 min on ice.
Cells were lysed by adding 1% Nonidet P-40 (Sigma) in PBS. After a
30 min incubation, TAP was immunoprecipitated from lysates with
anti-TAP2 antibody.
Supplementary material
Supplementary material including additional methodological detail is
available at http://current-biology.com/supmat/supmatin.htm.
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Supplementary materials and methods
Antibodies
Antibody 116/5 is a polyclonal rabbit antiserum recognising the car-
boxyl terminus of rat TAP2 chains [S1]. D90 is a polyclonal rabbit anti-
serum recognising the carboxyl terminus of rat TAP1 chains [S2]. F87
is a polyclonal rabbit antiserum against rat MHC class I RT1.A which
recognises predominantly RT1.Aa in western blots and immunoprecipi-
tations [S3]. Antibody 3B10.7 is a monoclonal rat anti-human class I
heavy chain (HLA-A and HLA-B) antibody [S4]. MA2.1 is a conforma-
tion-dependent mouse monoclonal antibody recognising HLA-A2 and
HLA-B17 [S5]. Antibody 4E is a conformation-dependent mouse mon-
oclonal antibody which recognises an epitope common to all HLA-B
and HLA-C antigens [S6]. Antibody W6/32 is a mouse monoclonal
antibody recognising b2microglobulin (b2m)-associated HLA-A, HLA-B
and HLA-C molecules [S7]. Anti-ER-60 antibody is a polyclonal rabbit
antiserum which recognises the thiol-dependent reductase ERp57
[S8]. PA3-900 is a rabbit polyclonal anti-calreticulin antibody (ABR).
R.gp48N is a rabbit polyclonal anti-peptide antibody to tapasin corre-
sponding to amino-terminal residues 2–20 [S9].
Peptide synthesis and labelling
Peptide A8 (AQASASRSA), the HLA-A2-binding IP-30-derived peptide
LLDVPTAAV [S10], the HLA-B5-binding peptide EBV-3C/881-9
QPRAPIRPI [S11] and the RT1.Aa-binding peptide AQFSASASR (B6)
[S12] were synthesised and purified by Eurogentec. Peptides S2
(SQYEANQSR), S8 (TVDNKTRYR) and S5 (TVDNKTRYV) were made
at the Microchemical Facility at the Babraham Institute using a Milligen
Biosearch 9500 synthesiser with FMOC chemistry. For radioiodination,
purified S8 peptide was dissolved in 100 mM phosphate buffer pH 7.5.
The labelling reaction was performed with 180 mM peptide and 0.5 mCi
Na125I. For peptide-binding assays, the photoreactive crosslinker N-
hydroxysuccinimidyl-4-azidobenzoate (HSAB; Pierce) was coupled to
iodinated peptide, according to the manufacturer’s instructions.
MHC class I stabilisation assay
This assay, which has been described previously [S13], makes use of
the TAP-deficient cell line T2, in which unstable MHC class I heavy
chain–b2m heterodimers are retained in the ER. MHC class I molecules
stabilised by suitable peptide can be detected by conformation-depen-
dent antibodies. Aliquots of radiolabelled T2 cells were lysed in PBS
containing 1% Triton-X100, in the absence or presence of allele-specific
binding peptides at increasing concentrations (0.1–100 mM). MHC class
I molecules were immunoprecipitated from post-nuclear lysate samples
with monoclonal antibody MA2.1 (anti-HLA-A antibody) and monoclonal
antibody 4E (anti-HLA-B antibody) and analysed by SDS–PAGE.
ATP depletion in cell lysates
For enzymatic depletion of intracellular dinucleotides and trinucleotides,
lysates were pretreated with 0.5 U apyrase/EC 3.6.1.5 (A 6410 from
Sigma) for 30 min at room temperature. Within this incubation time, the
ATP content decreases to £ 6% of the initial value (20–40 nmol/mg
protein). In nucleotide reconstitution experiments, the enzymatic activity
of apyrase was inactivated by 30 mM NaN3 [S14] after 30 min preincu-
bation. ATP levels were measured using luciferase assay kit from Sigma,
according to the manufacturer’s instructions, with a Berthold lumat LB
9507 luminometer (Berthold). Absolute ATP concentrations were deter-
mined by serial dilutions of cell extracts containing 50 mM Tris-H2SO4,
pH 7.4, 3.5 mM MgSO4×7H2O, 2.5 mM K2S04, 0.6 mM EDTA.
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